Premedix
Bratislava, Slovakia
Location status: Recruiting
Location contact
Allan Bohm, M.D., MSc. PhD.
CONTACT
Allan Bohm, M.D., MSc., PhD.
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07749183
This is a prospective study validating a new machine-learning algorithm that detects atrial fibrillation (AF) from photoplethysmography (PPG) signals, developed for integration into the Seerlinq remote monitoring platform. This algorithm builds on the same core PPG signal-processing technology as Seerlinq's HeartCore device, a CE-certified (Class IIb, MDR) device that monitors left ventricular filling pressures in heart failure patients. The algorithm will be validated through internal cross-validation, external validation against an independent cohort with paired PPG-ECG recordings, and validation in a cohort of patients with paroxysmal atrial fibrillation and frequent sinus-AF transitions.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Bratislava, Slovakia
Location status: Recruiting
Allan Bohm, M.D., MSc. PhD.
CONTACT
Allan Bohm, M.D., MSc., PhD.
PRINCIPAL_INVESTIGATOR
Atrial fibrillation (AF) and heart failure (HF) frequently coexist and share a bidirectional causal relationship; their concurrence is associated with worse clinical outcomes. Early detection of AF may enable timely intervention and improve outcomes. This study is prospectively validating a machine-learning algorithm for AF detection from PPG signals, intended for integration into the Seerlinq remote monitoring platform. This algorithm builds on the same core PPG signal-processing technology as Seerlinq's HeartCore device (a CE-certified, Class IIb device under the EU MDR that monitors left ventricular filling pressures in heart failure patients). It is a stand-alone algorithm designed specifically to detect clinically relevant (≥ 30s) atrial fibrillation.
Validation of the algorithm will proceed in three stages: (1) internal cross-validation; (2) external validation against an independent cohort with paired PPG-ECG recordings, to confirm generalizability; and (3) validation in a cohort of patients with paroxysmal atrial fibrillation and frequent sinus-AF transitions, to assess performance during clinically challenging rhythm changes.
The study is enrolling toward an estimated 1,000 unique PPG recordings. A 12-lead ECG is used to confirm cardiac rhythm classification (gold standard) as the reference for evaluating algorithm performance.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The PPG-based atrial fibrillation detection algorithm is a non-invasive signal processing approach that analyzes photoplethysmographic waveforms obtained during remote monitoring. The algorithm evaluates pulse-to-pulse variability, waveform characteristics, and signal quality parameters to identify irregular rhythm patterns associated with atrial fibrillation and provide early detection of potential arrhythmic events.
Time frame: Through study completion (estimated November 2026)
Time frame: Through study completion (estimated November 2026)
Time frame: Through study completion (estimated November 2026)
Time frame: Through study completion (estimated November 2026)
area under the precision-recall curve
Time frame: Through study completion (estimated November 2026)
e.g., calibration curve / Brier score
Time frame: Through study completion (estimated November 2026)
Time frame: Through study completion (estimated November 2026)
Time frame: Through study completion (estimated November 2026)
Time frame: Through study completion (estimated November 2026)
Contact information is provided by the study sponsor or research team.
Seerlinq s. r. o.
Other
Prospective Validation of a Machine-Learning Algorithm Using Photoplethysmography Signals for Early Detection of Atrial Fibrillation During Remote Telemonitoring
Acronym: HeartCore AF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07611084
Arrhythmias, Cardiac, Atrial Fibrillation
Taizhou, Jiangsu, China
View Trial DetailsNCT07217392
Arrhythmias, Cardiac, Atrial Fibrillation
Rio de Janeiro, Brazil
View Trial DetailsNCT07518446
Arrhythmias, Cardiac, Asthma
Copenhagen, Denmark
View Trial DetailsNCT07343895
Arrhythmias, Cardiac, Atrial Fibrillation
Tromsø, Norway
View Trial Details